SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q4 EPS of ($0.17), $0.17 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $12.92 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.